ALKEM LABORATORIES
Alkem Laboratories Share Price
Alkem Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Alkem Laboratories Investment Rating
-
Master Rating:
-
Alkem Laboratories has an operating revenue of Rs. 10,479.21 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 17% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
- Indicator
- Jun 2022
- Mar 2022
- Dec 2021
- Sep 2021
- Jun 2021
- Mar 2021
- Oper Rev Qtr Cr
- 2,058
- 2,006
- 2,181
- 2,364
- 2,279
- 1,917
- Operating Expenses Qtr Cr
- 1,875
- 1,807
- 1,709
- 1,776
- 1,728
- 1,501
- Operating Profit Qtr Cr
- 183
- 200
- 472
- 588
- 551
- 416
- Depreciation Qtr Cr
- 57
- 55
- 58
- 54
- 52
- 49
- Interest Qtr Cr
- 22
- 13
- 7
- 9
- 9
- 7
- Tax Qtr Cr
- 20
- 109
- 33
- 11
- 60
- 33
- Net Profit Qtr Cr
- 140
- 77
- 437
- 558
- 469
- 363
Alkem Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 3077.13
- 50 Day
- 3109.09
- 100 Day
- 3173.87
- 200 Day
- 3327.7
- 20 Day
- 3122.73
- 50 Day
- 3099.59
- 100 Day
- 3179.03
- 200 Day
- 3327.78
Alkem Laboratories Resistance and Support
- First Resistance
- 2981.3
- Second Resistance
- 3005.65
- Third Resistance
- 3031.3
- First Resistance
- 2931.3
- Second Resistance
- 2905.65
- Third Resistance
- 2881.3
- RSI
- 36.03
- MFI
- 54.69
- MACD Single Line
- -11.68
- MACD
- -40.52
Alkem Laboratories Delivery and Volume
- Period
- NSE + BSE
Volume Avg - NSE + BSE
Delivery Volume Avg - NSE + BSE
Delivery Volume %
- Day
- 438,708
- 17,350,901
- 39.55
- Week
- 253,551
- 13,225,207
- 52.16
- 1 Month
- 185,291
- 8,223,217
- 44.38
- 6 Month
- 115,516
- 5,960,621
- 51.6
Alkem Laboratories Result Highlights
Alkem Laboratories Synopsis
NSE-Medical-Diversified
Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8829.81 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2022. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.- Market Cap
- 35,240
- Sales
- 8,609
- Shares in Float
- 5.14
- No of funds
- 221
- Yield
- 1.15
- Book Value
- 4.03
- U/D Vol ratio
- 0.7
- LTDebt / Equity
- Alpha
- -0.1
- Beta
- 0.41
Alkem Laboratories
- Owner Name
- Jun-22
- Mar-22
- Dec-21
- Sep-21
- Promoters
- 57.14%
- 57.13%
- 57.13%
- Mutual Funds
- 7.85%
- 7.52%
- 7.25%
- Insurance Companies
- 6.03%
- 6.41%
- 6.51%
- Foreign Portfolio Investors
- 5.67%
- 5.41%
- 5.4%
- Financial Institutions/ Banks
- Individual Investors
- 22.33%
- 22.63%
- 22.86%
- Others
- 0.98%
- 0.9%
- 0.85%
Alkem Laboratories Management
- Name
- Designation
- Mr. Basudeo N Singh
- Executive Chairman
- Mr. Sandeep Singh
- Managing Director
- Mrs. Madhurima Singh
- Executive Director
- Mr. Balmiki Prasad Singh
- Executive Director
- Mr. Mritunjay Kumar Singh
- Executive Director
- Mr. Sarvesh Singh
- Executive Director
- Mr. Ranjal Laxmana Shenoy
- Independent Director
- Mr. Arun Kumar Purwar
- Independent Director
- Ms. Sangeeta Singh
- Independent Director
- Ms. Sudha Ravi
- Independent Director
- Dr. Dheeraj Sharma
- Independent Director
- Mr. Narendra Kumar Aneja
- Independent Director
Alkem Laboratories Forecast
Price Estimates
Alkem Laboratories Corporate Action
- Date
- Purpose
- Remarks
- 2022-08-05
- Quarterly Results
- 2022-05-13
- Audited Results & Final Dividend
- 2022-02-04
- Quarterly Results & Interim Dividend
- 2021-11-12
- Quarterly Results
- 2021-08-06
- Quarterly Results
- Date
- Purpose
- Remarks
- 2022-08-10
- FINAL
- Rs.4.00 per share(200%)Final Dividend
- 2022-02-12
- INTERIM
- Rs.30.00 per share(1500%)Interim Dividend
- 2021-08-10
- FINAL
- Rs.5.00 per share(250%)Final Dividend
- 2021-02-13
- INTERIM
- Rs.25.00 per share(1250%)Interim Dividend
Alkem Laboratories FAQs
What is Share Price of Alkem Laboratories ?
Alkem Laboratories share price is ₹2947 As on 17 August, 2022 | 01:11
What is the Market Cap of Alkem Laboratories ?
The Market Cap of Alkem Laboratories is ₹35240 Cr As on 17 August, 2022 | 01:11
What is the P/E ratio of Alkem Laboratories ?
The P/E ratio of Alkem Laboratories is 27 As on 17 August, 2022 | 01:11
What is the PB ratio of Alkem Laboratories ?
The PB ratio of Alkem Laboratories is 4 As on 17 August, 2022 | 01:11